CYTK - Cytokinetics Announces Five Presentations at the 34th International Symposium on ALS/MND | Benzinga
SOUTH SAN FRANCISCO, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced five presentations at the 34th International Symposium on ALS/MND taking place in Basel, Switzerland and online from December 6, 2023 - December 8, 2023.
Oral Presentations
Title: Site and Participant Perspectives on Participating in an ALS Trial Designed to Reduce Burden: COURAGE-ALS
Presenter: Stacy Rudnicki, M.D., Vice President, Clinical Research and Therapeutic Area Lead, Neuromuscular, Cytokinetics
Date: December 6, 2023
Session Title: Session 3B: Technology and Telemedicine
Session Time: 3:15-3:30 PM CET
Location: Singapore
Title: COURAGE-ALS: Results of the Phase 3 Clinical Trial of Reldesemtiv in ALS
Presenter: Jeremy M. Shefner, M.D., Ph.D., Professor of Neurology, Barrow Neurological Institute, University of Arizona College of Medicine Phoenix
Date: December 7, 2023
Session Title: Session 6B: Clinical Trials
Session Time: 10:30-10:50 AM CET
Location: Singapore
Poster Presentations
Title: Plasma Neurofilament Analysis in VITALITY-ALS: Analysis at Baseline, Longitudinal, and by Rate of Disease Progression
Presenter: Tyrell Simpkins, D.O., Ph.D., Associate Medical Director, Clinical Research Neuromuscular, Cytokinetics
Date: December 6, 2023
Session Title: Theme 10 – Disease Stratification and Phenotyping of Patient
Poster Number: DSP-08
Session Time: 6:45-7:45 PM CET
Location: Event Halle
Title: Hospitalizations in COURAGE-ALS and Their Relationship to ALS
Presenter: Stacy Rudnicki, M.D., Vice President, Clinical Research and Therapeutic Area Lead, Neuromuscular, Cytokinetics
Date: December 7, 2023
Session Title: Theme 09 – Clinical Trials and Trial Design
Poster Number: CLT-20
Session Time: 5:45-6:45 PM CET
Location: Event Halle
Title: Investigating Geographical Differences in Time from ALS Symptom Onset to Key Disease Milestones: Data from a Real-World Survey
Presenter: Paulos Gebrehiwet, Ph.D., M.S., Manager, Health Economics and Outcomes ...